Complex physical therapy employing self-adjusting garment (ReadyWrap®) in breast cancer-related lymphedema cases in Brazilian women: a protocol for a randomized controlled trial
- PMID: 37608354
- PMCID: PMC10464195
- DOI: 10.1186/s13063-023-07460-4
Complex physical therapy employing self-adjusting garment (ReadyWrap®) in breast cancer-related lymphedema cases in Brazilian women: a protocol for a randomized controlled trial
Abstract
Background: Lymphedema is a common complication following breast cancer treatment. The aim of this study is to evaluate the effectiveness of a self-adjusting compression garment (ReadyWrap®) in reducing (phase 1) and maintaining (phase 2) upper limb volume in women presenting breast cancer-related lymphedema.
Methods: This study will comprise a randomized, controlled, single-blind clinical trial concerning women with breast cancer-related lymphedema undergoing treatment at a public cancer treatment reference hospital in the city of Rio de Janeiro, Brazil. The intervention will be carried out by adapting self-dressing versus the standard treatment of compressive bandaging (phase 1) and compressive mesh (phase 2). Both groups will be assessed at the beginning and end of intensive treatment and followed up for up to 12 months to evaluate immediate and late outcomes. Assessments will be carried out by physical upper limb examination (inspection, palpation, volume, dynamometry, and thermography) and questionnaires application to assess patient's quality of life pertaining to the health, functionality, and symptoms of the affected upper limb, as well adverse effects and adherence to treatment. Data will be analyzed descriptively and analytically through univariate and multiple linear regressions. P values < 0.05 will be considered statistically significant.
Discussion: This study will evaluate the effectiveness of a self-adjustable garment (ReadyWrap®) in the treatment of lymphedema secondary to breast cancer in Brazilian women compared to the gold standard treatment for limb volume reduction (phase 1) and maintenance (phase 2) phases comprising, respectively, a compressive bandaging and a compressive mesh. The outcome results will provide data based on both quantitative responses and self-reported participant outcomes. The study will also assess the cost-effectiveness of the ReadyWrap® treatment versus standard care. Finally, we expect to reaffirm one more product/therapy as a treatment for this extremely complex and impactful condition following the data analysis.
Trial registration: NCT04934098 [Clinical trials phase 1]. Registered on June 22, 2021. NCT04881604 [Clinical trials phase 2]. Registered on May 11, 2021.
Keywords: Breast cancer lymphedema; Compression bandages; Physiotherapy; Rehabilitation medicine.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare a conflict of interest due to the donation of the compressive material used in the study by VENOSAN BRASIL LTDA. Despite this, the company does not present any associations that allow it to favorably change the results of this study to its interests. Therefore, the authors guarantee that they have complete freedom to publish the data.
Similar articles
-
Efficacy and efficiency of a new therapeutic approach based on activity-oriented proprioceptive antiedema therapy (TAPA) for edema reduction and improved occupational performance in the rehabilitation of breast cancer-related arm lymphedema in women: a controlled, randomized clinical trial.BMC Cancer. 2020 Nov 9;20(1):1074. doi: 10.1186/s12885-020-07558-x. BMC Cancer. 2020. PMID: 33167921 Free PMC article.
-
Efficacy, safety of and adherence to adjustable compression wraps in the control phase of breast cancer-related lymphedema: A randomized controlled trial.Clin Rehabil. 2024 Nov;38(11):1481-1494. doi: 10.1177/02692155241270921. Epub 2024 Aug 9. Clin Rehabil. 2024. PMID: 39119622 Clinical Trial.
-
Nighttime compression supports improved self-management of breast cancer-related lymphedema: A multicenter randomized controlled trial.Cancer. 2022 Feb 1;128(3):587-596. doi: 10.1002/cncr.33943. Epub 2021 Oct 6. Cancer. 2022. PMID: 34614195 Clinical Trial.
-
Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.Breast Cancer Res Treat. 2023 Feb;198(1):1-9. doi: 10.1007/s10549-022-06850-7. Epub 2022 Dec 24. Breast Cancer Res Treat. 2023. PMID: 36566297 Free PMC article. Review.
-
New insights in breast cancer-related lymphedema.J Med Vasc. 2024 Sep;49(3-4):135-140. doi: 10.1016/j.jdmv.2024.06.001. Epub 2024 Jul 10. J Med Vasc. 2024. PMID: 39278693 Review.
Cited by
-
Exploring the Impact of Physical Therapy on Patient Outcomes Across the Cancer Care Continuum: A Narrative Review.Cureus. 2025 Jul 1;17(7):e87144. doi: 10.7759/cureus.87144. eCollection 2025 Jul. Cureus. 2025. PMID: 40755583 Free PMC article. Review.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical